Imatinib Mesylate — The New Gold Standard for Treatment of Chronic Myeloid Leukemia
Year: 2003
Type: editorial
Source: New England Journal of Medicine
DOI: 10.1056/nejme030009
Authors: Karl Peggs, Stephen Mackinnon
Institutions: The Royal Free Hospital, University College London
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2030154801
